Homeopathy World Community

Creating Waves of Awareness

How Many Scientists Fabricate And Falsify Research?

ScienceDaily (May 29, 2009) — It's a long-standing and crucial question that, as yet, remains unanswered: just how common is scientific misconduct? In the online, open-access journal PLoS ONE, Daniele Fanelli of the University of Edinburgh reports the first meta-analysis of surveys questioning scientists about their misbehaviours. The results suggest that altering or making up data is more frequent than previously estimated and might be particularly high in medical research.
See Also:
Science & Society

Recent scandals like Hwang Woo-Suk's fake stem-cell lines or Jon Sudbø's made-up cancer trials have dramatically demonstrated that fraudulent research is very easy to publish, even in the most prestigious journals. The media and many scientists tend to explain away these cases as pathological deviations of a few "bad apples." Common sense and increasing evidence, however, suggest that these could be just the tip of the iceberg, because fraud and other more subtle forms of misconduct might be relatively frequent. The actual numbers, however, are a matter of great controversy.

Estimates based on indirect data (for example, official retractions of scientific papers or random data audits) have produced largely discrepant results. Therefore, many researchers have asked scientists directly, with surveys conducted in different countries and disciplines. However, they have used different methods and asked different questions, so their results also appeared inconclusive.

To make these surveys comparable, the meta-analysis focused on behaviours that actually distort scientific knowledge (excluding data on plagiarism and other kinds of malpractice) and extracted the frequency of scientists who recalled having committed a particular behaviour at least once, or who knew a colleague who did.

On average, across the surveys, around 2% of scientists admitted they had "fabricated" (made up), "falsified" or "altered" data to "improve the outcome" at least once, and up to 34% admitted to other questionable research practices including "failing to present data that contradict one's own previous research" and "dropping observations or data points from analyses based on a gut feeling that they were inaccurate."

In surveys that asked about the behaviour of colleagues, 14% knew someone who had fabricated, falsified or altered data, and up to 72% knew someone who had committed other questionable research practices.

In both kinds of surveys, misconduct was reported most frequently by medical and pharmacological researchers. This suggests that either the latter are more open and honest in their answers, or that frauds and bias are more frequent in their fields. The latter interpretation would support growing fears that industrial sponsorship is severely distorting scientific evidence to promote commercial treatments and drugs.

As in all surveys asking sensitive questions, it is likely that some respondents did not reply honestly, especially when asked about their own behaviour. Therefore, a frequency of 2% is probably a conservative estimate, while it remains unclear how the figure of 14% should be interpreted.

Views: 6

Replies to This Discussion

some more on this subject; www.pharmedout.org
pharmaceutical marketing and what consumers need to know.
www.AHRP.org
alliance for human research-ethical medical research practices
www.wddty.com
what doctors dont tell you-many eye opening articles
www.pnc.comau/~cafmr
drug racket,medical corruption
Former Pfizer representative charged with health care fraud
01/15/2010
By Lee Howard

http://www.theoneclickgroup.co.uk/news.php?start=3200&end=3220&...

Dr. Scott S. Reuben, a former member of Pfizer Inc.’s speakers’ bureau accused last year of perpetrating one of the biggest research frauds in medical history, was charged today in a federal court in Boston with falsifying medical research studies.

Reuben, formerly chief of acute pain at Baystate Medical Center in Springfield, Mass., faces up to 10 years in prison and a $250,000 fine.

U.S. Attorney Carmen M. Ortiz accused Reuben of accepting a $75,000 grant from Pfizer to research the effectiveness of pain medication Celebrex for a 2005 study in which no patients were actually enrolled. Prosecutors allege that Reuben made up the data, which he subsequently published in the medical journal "Anesthesia & Analgesia."

The data supported the conclusion that Celebrex was effective in helping post-operative patients who had received a particular type of knee surgery on the anterior cruciate ligament. "Anesthesia & Analgesia" later had to retract 10 papers written by Reuben, and medical experts at the time said at least 21 journal articles by the anesthesiologist appeared to be fabricated.

Reuben’s studies had been considered pioneering at the time they were published. His data had supported the use of two of Pfizer’s major products — Celebrex and Lyrica — in combination to treat certain types of post-operative pain.

Pfizer said it had supported five of Reuben’s research initiatives. Pfizer, which declined at the time to reveal how much it paid Reuben over the years to be part of its speakers’ bureau, said the company played no part in the fraud.

Last March, Reuben was dismissed from his position at Baystate Medical Center after an audit revealed he had been inventing data for as many as 13 years.

RSS

RADIO & VIDEO SHOWS

Badge

Loading…

Join Twitter

Show your allegiance to Homeopathy Click the TWEET BUTTON!

Photos

Loading…
  • Add Photos
  • View All

© 2013   Created by Debby Bruck.

Badges  |  Report an Issue  |  Terms of Service

Related Posts Plugin for WordPress, Blogger...